HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Maraver Selected Research

Monoclonal Antibodies

1/2018An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Maraver Research Topics

Disease

14Neoplasms (Cancer)
11/2023 - 07/2007
5Lung Neoplasms (Lung Cancer)
11/2023 - 01/2018
3Adenocarcinoma of Lung
11/2023 - 01/2020
3Neoplasm Metastasis (Metastasis)
05/2021 - 01/2012
2Carcinogenesis
03/2024 - 11/2021
2Carcinoma (Carcinomatosis)
11/2023 - 08/2012
1Colorectal Neoplasms (Colorectal Cancer)
03/2024
1Colonic Neoplasms (Colon Cancer)
03/2024
1Breast Neoplasms (Breast Cancer)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021
1Cachexia
01/2020
1Opportunistic Infections (Opportunistic Infection)
01/2020
1Disease Progression
01/2020
1Hypertension (High Blood Pressure)
04/2015
1Cardiomegaly (Heart Hypertrophy)
04/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2012

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2007
3osimertinibIBA
07/2021 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
07/2021 - 01/2018
2Tyrosine Kinase InhibitorsIBA
07/2021 - 01/2020
2Therapeutic UsesIBA
01/2020 - 08/2012
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
04/2015 - 08/2012
1Nuclear Receptor Co-Repressor 1IBA
03/2024
1Transcription Factors (Transcription Factor)IBA
03/2024
1Carrier Proteins (Binding Protein)IBA
03/2024
1Biomarkers (Surrogate Marker)IBA
11/2023
1Volatile Organic CompoundsIBA
11/2023
14-sulfophenylmethallyl ether (SPME)IBA
11/2023
1Doxycycline (Periostat)FDA LinkGeneric
11/2023
1RNA (Ribonucleic Acid)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Metalloproteases (Metalloproteinases)IBA
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
1Phenobarbital (Luminal)FDA Link
11/2021
1CrizotinibIBA
07/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021
1pembrolizumabIBA
05/2021
1LigandsIBA
01/2021
1demcizumabIBA
01/2021
1PlatinumIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1ElementsIBA
01/2020
1Gefitinib (Iressa)FDA Link
01/2020
1Monoclonal AntibodiesIBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1Trastuzumab (Herceptin)FDA Link
01/2018
1Muscle Proteins (Muscle Protein)IBA
08/2016
1Troponin IIBA
08/2016
1Angiotensin IIIBA
04/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2012
1Messenger RNA (mRNA)IBA
01/2012
1MicroRNAs (MicroRNA)IBA
01/2012
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2008

Therapy/Procedure

2Immunotherapy
01/2022 - 05/2021
2Drug Therapy (Chemotherapy)
01/2020 - 01/2020
1Aftercare (After-Treatment)
07/2021
1Thymectomy
01/2021
1Splenectomy
01/2021